Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (3) , 745-749
- https://doi.org/10.1016/j.bmcl.2006.10.076
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Targeting the dopamine D2receptor in schizophreniaEmerging Therapeutic Targets, 2006
- Recent advances towards the discovery of dopamine receptor ligandsExpert Opinion on Therapeutic Patents, 2006
- Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic AgentsJournal of Medicinal Chemistry, 2005
- Dopamine in drug abuse and addiction: results from imaging studies and treatment implicationsMolecular Psychiatry, 2004
- Half a century of antipsychotics and still a central role for dopamine D2 receptorsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric DisordersCurrent Pharmaceutical Design, 2003
- Pathogenesis of parkinson's disease: dopamine, vesicles and α-synucleinNature Reviews Neuroscience, 2002
- Behavioral effects of cocaine and dopaminergic strategies for preclinical medication developmentPsychopharmacology, 2002
- Dopamine Receptors: From Structure to FunctionPhysiological Reviews, 1998
- 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 ReceptorJournal of Medicinal Chemistry, 1996